Assessment of the efficacy of functional food ingredients - Introducing the concept "kinetics of biomarkers"

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 551, Issue 1-2, 2004, Pages 65-78

  Verhagen, Hans ^a   Coolen, Stefan ^a   Duchateau, Guus ^a   Hamer, Mark ^a   Kyle, Janet ^a   Rechner, Andreas ^a  

^a UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

Author keywords

Biomarkers; Dietary intervention; Functional foods; Health claims

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; GLUTATHIONE TRANSFERASE; INTERLEUKIN 6; ISOPROSTANE DERIVATIVE; POLYPHENOL;

ABSORPTION; BEVERAGE; CIRCADIAN RHYTHM; CYTOKINE PRODUCTION; EXCRETION; FOOD INTAKE; HUMAN; KINETICS; MALARIA; MEDICAL ASSESSMENT; MEDICAL RESEARCH; METABOLISM; NONHUMAN; NUTRITION; PRIORITY JOURNAL; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

BIOLOGICAL MARKERS; FOOD; FOOD LABELING; HEALTH FOOD; HUMANS; KINETICS; NUTRITIVE VALUE; RESEARCH DESIGN;

EID: 3042593711     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2004.01.013     Document Type: Review

References (65)

1. Bellisle F., Diplock A.T., Hornstra G., Koletzko B., Roberfroid M., Salminen J., Saris W.H.M. Functional Food Science in Europe. Br. J. Nutr. 80:1998;S1-S193
2. Weststrate J.A., van Poppel G., Verschuren P.M. Functional foods, trends and future. Br. J. Nutr. 88:2002;S233-S235
3. Diplock A., Aggett P., Ashwell M., Bornet F., Fern E., Roberfroid M. Scientific concepts of functional foods in Europe Consensus Document. Br. J. Nutr. 81:1999;S1-S27
4. Richardson D.P., Affertsholt T., Asp N.G., Bruce Å., Grossklaus R., Howlett J., Ross H., Verhagen H., Viechtbauer V. Process for the assessment of scientific support for claims on foods - PASSCLAIM. Eur. J. Clin. Nutr. 42(Suppl. 1):2003;96-111
5. Cummings J.H., Pannemans D., Persin C. PASSCLAIM - Report of the First Plenary Meeting including a set of interim criteria to scientifically substantiate claims on foods. Eur. J. Clin. Nutr. 42(Suppl 1):2003;112-119
6. Mensink R.P., Aro A., Den Hond E., German J.B., Griffin B.A., ten Meer H.U., Mutanen M., Pannemans D., Stahl W. PASSCLAIM - diet-related cardiovascular disease. Eur. J. Clin. Nutr. 42(Suppl. 1):2003;6-27
7. Saris W.H., Antoine J.M., Brouns F., Fogelholm M., Gleeson M., Hespel P., Jeukendrup A.E., Maughan R.J., Pannemans D., Stich V. PASSCLAIM - physical performance and fitness. Eur. J. Clin. Nutr. 42(Suppl. 1):2003;50-95
8. Prentice A., Bonjour J.P., Branca F., Cooper C., Flynn A., Garabedian M., Muller D., Pannemans D., Weber P. PASSCLAIM - bone health and osteoporosis. Eur. J. Clin. Nutr. 42(Suppl. 1):2003;28-49
9. Verhagen H., van Poppel G., Willems M.I., Bogaards J.J.M., Rompelberg C.J.M., van Bladeren P.J. Cancer prevention by natural food constituents. Int. Food Ingred. 1-2:1993;22-29
10. G. van Poppel, H. Verhagen, B. Heinzow, Biomarkers in epidemiological and toxicological nutrition research, in: D. Tennant (Ed.), Food Chemical Risk Analysis, Chapman and Hall, 1997, pp. 87-108.
11. Crews H., Alink G., Andersen R., Braesco V., Holst B., Maiani G., Ovesen L., Scotter M., Solfrizzo M., van Den Berg R., Verhagen H., Williamson G. A critical assessment of some biomarker approaches linked with dietary intake. Br. J. Nutr. 86(Suppl. 1):2001;S37-S53
12. Wild C.P., Andersson C., O'Brien N.M., Wilson L., Woods J.A. A critical evaluation of the application of biomarkers in epidemiological studies on diet and health. Br. J. Nutr. 86(Suppl. 1):2001;S37-S53
13. Branca F., Hanley A.B., Pool-Zobel B., Verhagen H. Biomarkers in disease and health. Br. J. Nutr. 86(Suppl. 1):2001;S55-S92
14. Verhagen H., Aruoma O.I., van Delft J.H.M., Dragsted L.O., Ferguson L.R., Knasmüller S., Pool-Zobel B.L., Poulsen H.E., Williamson G., Yannai S. Editorial - The 10 basic requirements for a scientific paper reporting antioxidant, antimutagenic or anticarcinogenic potential of test substances in in vitro experiments and animal studies in vivo. Food Chem. Toxicol. 41:2003;603-610
15. H. Verhagen, S. Coolen, G. Duchateau, J. Mathot, T. Mulder, Bioanalysis and biomarkers: the tool and the goal, in: W. Pfannhauser, G.R. Fenwick, S. Khokhar (Eds.), Proceedings of the EUROFOODCHEM XI meeting "Biologically- active Phytochemicals in Food: Analysis, Metabolism, Bioavailability and Function" of the Biologically-active phytochemicals in food, Norwich, UK, 26-28 September 2001. The Royal Society of Chemistry, Special publication no. 269, Cambridge, UK, pp. 125-130.
16. Nicholson J.K., Connelly J., Lindon J.C., Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 1:2002;153-161
17. Verhagen H., Rompelberg C.J.M., Strube M., van Poppel G., van Bladeren P.J. Cancer prevention by dietary constituents in toxicological perspective. J. Environ. Pathol. Toxicol. Oncol. 16:1997;343-360
18. van het Hof K.H., Wiseman S.A., Yang C.S., Tijburg L.B. Plasma and lipoprotein levels of tea catechins following repeated tea consumption. Proc. Soc. Exp. Biol. Med. 220:1999;203-209
19. van het Hof K.H., Brouwer I.A., West C.E., Haddeman E., Steegers-Theunissen R.P., van Dusseldorp M., Weststrate J.A., Eskes T.K., Hautvast J.G. Bioavailability of lutein from vegetables is 5 times higher than that of beta-carotene. Am. J. Clin. Nutr. 70:1999;261-268
20. Paetau I., Khachik F., Brown E.D., Beecher G.R., Kramer T.R., Chittams J., Clevidence B.A. Chronic ingestion of lycopene-rich tomato juice or lycopene supplements significantly increases plasma concentrations of lycopene and related tomato carotenoids in humans. Am. J. Clin. Nutr. 68:1998;1187-1195
21. Morrow J.D., Roberts L.J. The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease. Am. J. Respir. Crit. Care Med. 15:2002;S25-S30
22. Offord E., van Poppel G., Tyrrell R. Markers of oxidative damage and antioxidant protection: current status and relevance to disease. Free Radic. Res. 33:2001;S5-S19
23. Griffiths H.R., Moller L., Bartosz G., Bast A., Bertoni-Freddari C., Collins A., Cooke M., Coolen S., Haenen G., Hoberg A.M., Loft S., Lunec J., Olinski R., Parry J., Pompella A., Poulsen H., Verhagen H., Astley S.B. Biomarkers. Mol. Aspects. Med. 1-3:2002;101-208
24. J. Rafter, M. Govers, P. Martel, B. Pool-Zobel, G. Rechkemmer, I. Rowland, J. van Loo, PASSCLAIM - diet-related cancer, Eur. J. Nutr., in press.
25. G. Riccardi, P. Aggett, F. Bringhenti, N. Delzenne, K. Frayn, A. Nieuwenhuizen, S. Theis, B. Vessby, PASSCLAIM - Body weight regulation, insulin sensitivity and diabetes risk. Eur. J. Nutr., in press.
26. J. Westenhoefer, F. Bellisle, J.E. Blundell, J. de Vries, D. Edwards, W. Kallus, H. Milon, H. Tuorila, PASSCLAIM - mental state and performance, Eur. J. Nutr., in press.
27. J. Cummings, J.M. Antoine, F. Azpiroz, R. Bourdet Sicard, P. Brandtzaeg, P.C. Calder, G.R. Gibson, F. Guerner, E. Isolauri, C. Shortt, B. Watzl, PASSCLAIM - gut health and immunity, Eur. J. Nutr., in press.
28. Blüher M., Hentschel B., Rassoul F., Richter V. Influence of dietary intake and physical activity on annual rythm of human blood cholesterol concentrations. Chronobiol. Int. 18:2001;541-557
29. Shefer S., Hauser S., Lapar V., Mosbach E.H. Diurnal variation of HMG CoA reductase activity in the rat. J. Lipid Res. 13:1972;571-573
30. Spencer J.P., Schroeter H., Crossthwaithe A.J., Kuhnle G., Williams R.J., Rice-Evans C. Contrasting influences of glucuronidation and O-methylation of epicatechin on hydrogen peroxide-induced cell death in neurons and fibroblasts. Free Rad. Biol. Med. 31:2001;1139-1146
31. Spencer J.P., Kuhnle G.G., Williams R.J., Rice-Evans C. Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites. Biochem. J. 372:2003;173-181
32. A.R. Rechner, M.A. Smith, G. Kuhnle, G.R. Gibson, E.S. Debnam, S.K. Srai, K.P. Moore, C.A. Rice-Evans, Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products, Free Rad. Biol. Med., in press.
33. Aura A.M., O'Leary K.A., Williamson G., Ojala M., Bailey M., Puupponen-Pimia R., Nuutila A.M., Oksman-Caldentey K.M., Poutanen K. Quercetin derivatives are deconjugated and converted to hydroxyphenylacetic acids but not methylated by human fecal flora in vitro. J. Agric. Food Chem. 50:2002;1725-1730
34. Rechner A.R., Kuhnle G., Bremner P., Hubbard G.P., Moore K.P., Rice-Evans C.A. The metabolic fate of dietary polyphenols in humans. Free Rad. Biol. Med. 33:2002;220-235
35. Booth A.N., Emerson O.H., Jones F.T., Deeds F. Urinary metabolites of caffeic and chlorogenic acids. J. Biol. Chem. 229:1957;51-59
36. Grosse Düweler K., Rohdewald P. Urinary metabolites of French maritime pine bark extract in humans. Pharmazie. 55:2000;364-368
37. Rechner A.R., Spencer J.P.E., Kuhnle G., Hahn U., Rice-Evans C.A. Novel biomarkers of the bioavailability and metabolism of caffeic acid derivatives in humans. Free Rad. Biol. Med. 30:2001;1213-1222
38. Clifford M.N., Copeland E.L., Bloxsidge J.P., Mitchell L.A. Hippuric acid as a major excretion product associated with black tea consumption. Xenobiotica. 50:2000;317-326
39. Olthof M.R., Hollman P.C.H., Buijsman M.N.C.P., Van Amelsfoort J.M.M., Katan M.B. Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans. J. Nutr. 133:2003;1806-1814
40. Scalbert A., Williamson G. Dietary intake and bioavailability of polyphenols. J. Nutr. 130:2000;2073S-2085S
41. Verhoeven D.T.H., Verhagen H., Goldbohm R.A., van den Brandt P.A., van Poppel G. A review of mechanisms underlying anticarcinogenicity by brassica vegetables. Chem. Biol. Interact. 103:1997;79-129
42. van Iersel M.L.P.S., Verhagen H., van Bladeren P.J. The role of biotransformation in dietary (anti) carcinogenesis. Mutat. Res. 443:1999;259-270
43. G. van Poppel, D.T.H. Verhoeven, H. Verhagen, R.A. Goldbohm, Brassica vegetables and cancer prevention: epidemiology and mechanisms, Advances in Experimental Medicine and Biology, vol. 472, in: Zappia, et al. (Eds.), Advances in Nutrition and Cancer, vol. 2, Kluwer Academic/Plenum Publishers, 1999, pp. 159-168.
44. Beckett G.J., Dyson E.H., Chapman B.J., Templeton A.J., Hayes J.D. Plasma glutathione S-transferase measurements by radioimmunoassay: a sensitive index of hepatocellular damage in man. Clin. Chim. Acta. 146:1985;11-19
45. Kensler T.W., Egner P.A., Wang J.B., Zhu Y.R., Zhang B.C., Qian G.S., Kuang S.Y., Gange S.J., Jacobson L.P., Munoz A., Groopman J.D. Strategies for chemoprevention of liver cancer. Eur. J. Cancer Prev. 11:2002;S58-64
46. Kensler T.W., Davidson N.E., Groopman J.D., Munoz A. Biomarkers and surrogacy: relevance to chemoprevention. IARC Sci. Publ. 154:2001;27-47
47. Kensler T.W., Groopman J.D., Sutter T.R., Curphey T.J., Roebuck B.D. Development of cancer chemopreventive agents: oltipraz as a paradigm. Chem. Res. Toxicol. 12:1999;113-126
48. Basu S., Liu X., Nozari A., Rubertsson S., Miclescu A., Wiklund L. Evidence for time-dependent maximum increase of free radical damage and eicosanoid formation in the brain as related to duration of cardiac arrest and cardio-pulmonary resuscitation. Free Radic. Res. 37:2003;251-256
49. Ohashi N., Yoshikawa M. Rapid and sensitive quantification of 8-isoprostaglandin F2alpha in human plasma and urine by liquid chromatography-electrospray ionization mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl. 746:2000;17-24
50. Murai Y., Hishinuma T., Suzuki N., Satoh J., Toyota T., Mizugaki M. Determination of urinary 8-epi-prostaglandin F(2alpha) using liquid chromatography-tandem mass spectrometry: increased excretion in diabetics. Prostaglandins other Lipid Mediat. 62:2000;173-181
51. Coolen S.A.J., van der Ham M., Wiseman S.A., Verhagen H. Fast and sensitive determination of free and esterified 15-F2t-isoprostanes in plasma with high performance liquid chromatography tandem mass spectrometry. Free Radical Res. 36(Suppl. 1):2001;120
52. Akira S., Taga T., Kishimoto T. Interleukin-6 in biology and medicine. Adv. Immunol. 54:1993;1-78
53. Febbraio M.A., Pedersen B.K. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J. 16:2002;1335-1347
54. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., Lotsikas A., Zachman K., Kales A., Prolo P., Wog M-L., Licinio J., Gold P.W., Hermida R.C., Mastorakos G., Chrousos G.P. Circadian interleukin-6 secretion and quantity and depth of sleep. J. Clin. Endocr. Metabol. 84:1999;2603-2607
55. Steptoe A., Willemsen G., Owen N., Flower L., Mohamed-Ali V. Acute mental stress elicits delayed increases in circulating inflammatory cytokine levels. Clin. Sci. 101:2001;185-192
56. Pedersen B.K., Steensberg A., Fischer C., Keller C., Ostrowski K., Schjerling P. Exercise and cytokines with particular focus on muscle-derived IL-6. Ex. Immunol. Rev. 7:2001;18-31
57. Starkie R.L., Arkinstall M.J., Koukoulas I., Hawley J.A., Febbraio M.A. Carbohydrate ingestion attenuates the increase in plasma interleukin 6, but not skeletal muscle interleukin 6 mRNA, during exercise in humans. J. Physiol. 533:2001;585-591
58. Pedersen B.K., Bruunsgaard H., Klokker M., Kappel M., MacLean D.A., Nielsen H.B., Rohde T., Ullum H., Zacho M. Exercise-induced immunomodulation - possible roles of neuroendocrine factors and metabolic factors. Int. J. Sports Med. 18:1997;S2-S7
59. Hellsten Y., Frandsen U., Orthenblad N., Sjodin N., Richter E.A. Xanthine oxidase in human skeletal muscle following eccentric exercise: a role of inflammation. J. Physiol. 498:1997;239-248
60. Nehlsen-Cannarella S.L., Fagoaga O.R., Nieman D.C., Henson D.A., Butterworth D.E., Schmitt R.L., Bailey E.M., Warren B.J., Utter A., Davis J.M. Carbohydrate and the cytokine response to 2.5h of running. J. Appl. Physiol. 82:1997;1662-1667
61. Emberson J.R., Whincup P.H., Walker M., Thomas M., Alberti K.G.M.M. Biochemical measures in a population-based study: effect of fasting duration and time of day. Ann. Clin. Biochem. 39:2002;493-501
62. Smith S.J., Cooper G.R., Myers G.L., Sampson E.J. Biological variability in concentration of serum lipids - sources of variation among results from published studies and composite predicted values. Clin. Chem. 39:1993;1012-1022
63. Wasenius A., Stugaard M., Otterstad J.E., Froyshov D. Diurnal and monthly intra-individual variability of the concentration of lipids, lipoproteins and apoproteins. Scand. J. Clin. Lab. Invest. 50:1990;635-642
64. Halkes C.J.M., Cabezas M.C., van Wijk J.P.H., Erkelens D.W. Gender differences in diurnal triglyceridemia in lean and overweight subjects. Int. J. Obesity. 25:2001;1767-1774
65. Holmback U., Forslund A., Forslund J. Metabolic responses to nocturnal eating in men are affected by sources of dietary energy. J. Nutr. 132:2002;1892-1899